SNYYF yields 2.66% · JNJ yields 2.13%● Live data
📍 SNYYF pulled ahead of the other in Year 1
Combined, SNYYF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of SNYYF + JNJ for your $10,000?
Sany Heavy Equipment International Holdings Company Limited, an investment holding company, engages in the manufacture and sale of mining equipment, logistics equipment, robotic, smart mine products, and spare parts. It operates in two segments, Mining Equipment and Logistics Equipment. The Mining Equipment segment provides coal mining machinery products, including road headers, such as soft rock and hard rock road headers, integrated excavation, bolting, and self-protection machinery; mining equipment consisting of coal mining machines, hydraulic support system, scraper conveyors, etc.; non-coal mining machinery products comprising tunnel road headers and mining machines; mining transport equipment, including mechanical drive off-highway and electric drive off-highway dump trucks, widebody vehicles, and other relevant products; spare parts; robotic products, such as robotic system integration, mobile robots, and electric forklifts; and smart mine products, including unmanned driving, automated integrated mining, and smart mine operation systems. The Logistic Equipment segment offers container equipment, such as front loaders, stacking machines and quayside gantry cranes, etc.; bulk material equipment, which comprise grippers, elevated hoisting arms, etc.; and general equipment, including heavy-weight forklifts, telehandlers, etc. In addition, the company provides maintenance and property development services. It operates in Mainland China, rest of Asia, the European Union, the United States, and internationally. The company was founded in 2004 and is headquartered in Shenyang, the People's Republic of China. Sany Heavy Equipment International Holdings Company Limited is a subsidiary of Sany Hongkong Group Limited.
Full SNYYF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.